0001801385-24-000002.txt : 20240124
0001801385-24-000002.hdr.sgml : 20240124
20240124174440
ACCESSION NUMBER: 0001801385-24-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240122
FILED AS OF DATE: 20240124
DATE AS OF CHANGE: 20240124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Romano Kathryn
CENTRAL INDEX KEY: 0001801385
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38210
FILM NUMBER: 24558003
MAIL ADDRESS:
STREET 1: C/O KRYSTAL BIOTECH, INC.
STREET 2: 2100 WHARTON STREET, SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Krystal Biotech, Inc.
CENTRAL INDEX KEY: 0001711279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 821080209
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
BUSINESS PHONE: (412) 586-5830
MAIL ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
4
1
wk-form4_1706136270.xml
FORM 4
X0508
4
2024-01-22
0
0001711279
Krystal Biotech, Inc.
KRYS
0001801385
Romano Kathryn
C/O KRYSTAL BIOTECH, INC.
2100 WHARTON STREET, SUITE 701
PITTSBURGH
PA
15203
0
1
0
0
Chief Accounting Officer
1
Common Stock
2024-01-22
4
M
0
2500
52.26
A
15056
D
Common Stock
2024-01-22
4
S
0
2500
130
D
12556
D
Stock Option (Right to Buy)
52.26
2024-01-22
2024-01-22
4
M
0
2500
0
D
2030-01-30
Common Stock
2500
10000
D
The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on August 29, 2023 and will terminate on June 28, 2024 and contemplates option exercises and sales of 2,500 shares with a limit price of $130.00 per share.
The transaction was executed in one trade.
50,000 options were granted that vest in four equal annual installments beginning on January 20, 2021.
/s/ Kathryn Romano
2024-01-24